Plurify
PrivateLast Round
Grant
Jul 21, 2026
Total Funding Raised
$2.21M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Plurify operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Grant round in July 2026.
Plurify is a biotechnology company that has developed a scalable molecular purification platform designed to eliminate unwanted cells during the manufacturing of stem cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Plurify Comparables
Compare Plurify with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pluristyx | 79% | |
| TreeFrog Therapeutics | 77% | |
| Mogrify | 74% |
For institutional investors. Book with your work email.
Plurify Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 21, 2026 | ||||
| Grant | Jun 20, 2024 | ||||
| Accelerator | May 1, 2024 | ||||
| Seed | Jan 5, 2024 | ||||
| Accelerator | Jul 14, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Plurify Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Science Ventures | Seed, Accelerator |
| Cell and Gene Therapy Catapult | Seed |
| British Business Bank | Grant |
| Exceptional Ventures | Grant |
| Innovate UK | Grant |
| Science Creates | Accelerator |
| Kadmos Capital | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 508% MoM, from 485 to 2.9K.
- Jul 21, 2026
$1.76M grant received from Exceptional Ventures and Kadmos Capital.
For institutional investors. Book with your work email.
Plurify Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Plurify's valuation, stock price, and market status.
Is Plurify a public or private company?
Plurify is a private company.
What is the current stock price of Plurify?
Plurify is a private company, so its shares have no public market price. Caplight tracks Plurify's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Plurify worth (valuation)?
Valuation information for Plurify is not publicly available.
Can I buy Plurify stock?
Plurify shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Plurify's last funding round?
Plurify's most recent funding round was Grant on July 21, 2026.
Who are the main investors in Plurify?
Key investors in Plurify include Deep Science Ventures, Cell and Gene Therapy Catapult, British Business Bank, Exceptional Ventures, Innovate UK.
Will Plurify IPO soon?
No public IPO plans have been announced for Plurify.
How can I track Plurify secondary market activity?
Caplight tracks bids, offers, and trades in Plurify's shares on secondary markets.